Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Dunne

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
Gut|January 29, 2025
Low-coverage whole genome sequencing of low-grade dysplasia strongly predicts advanced neoplasia risk in ulcerative colitisIbrahim Al Bakir, Kit Curtius, George D Cresswell, et al.
Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Low coverage whole genome sequencing of low-grade dysplasia strongly predicts colorectal cancer risk in ulcerative colitisIbrahim Al Bakir, Kit Curtius, George D Cresswell, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2020
The pseudo-caspase FLIP(L) regulates cell fate following p53 activationAndrea Lees, Alexander J McIntyre, Nyree T Crawford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2026
Differential Immunological Effects of Short-Course and Long-Course Radiotherapy in Locally Advanced Rectal CancerLily V S Hillson, Ross K McMahon, Norman J Galbraith, et al.
JCO Precision Oncology|August 9, 2018
Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapyW L Allen, P D Dunne, S McDade, et al.
Nature|June 4, 2025
Loss of colonic fidelity enables multilineage plasticity and metastasisPatrizia Cammareri, Michela Raponi, Yourae Hong, et al.
Nature Genetics|December 18, 2025
Nucleophosmin supports WNT-driven hyperproliferation and tumor initiationGeorgios Kanellos, Chiara Giacomelli, Alexander Raven, et al.
Cell Stem Cell|November 4, 2022
Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasiaEster Gil Vazquez, Nadia Nasreddin, Gabriel N Valbuena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal CancerSudhir B Malla, David J Fisher, Enric Domingo, et al.
Cell Stem Cell|August 5, 2022
Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasiaEster Gil Vasquez, Nadia Nasreddin, Gabriel N Valbuena, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Gut|January 29, 2025
Low-coverage whole genome sequencing of low-grade dysplasia strongly predicts advanced neoplasia risk in ulcerative colitisIbrahim Al Bakir, Kit Curtius, George D Cresswell, et al.
Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Low coverage whole genome sequencing of low-grade dysplasia strongly predicts colorectal cancer risk in ulcerative colitisIbrahim Al Bakir, Kit Curtius, George D Cresswell, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2020
The pseudo-caspase FLIP(L) regulates cell fate following p53 activationAndrea Lees, Alexander J McIntyre, Nyree T Crawford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2026
Differential Immunological Effects of Short-Course and Long-Course Radiotherapy in Locally Advanced Rectal CancerLily V S Hillson, Ross K McMahon, Norman J Galbraith, et al.
JCO Precision Oncology|August 9, 2018
Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapyW L Allen, P D Dunne, S McDade, et al.
Nature|June 4, 2025
Loss of colonic fidelity enables multilineage plasticity and metastasisPatrizia Cammareri, Michela Raponi, Yourae Hong, et al.
Nature Genetics|December 18, 2025
Nucleophosmin supports WNT-driven hyperproliferation and tumor initiationGeorgios Kanellos, Chiara Giacomelli, Alexander Raven, et al.
Cell Stem Cell|November 4, 2022
Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasiaEster Gil Vazquez, Nadia Nasreddin, Gabriel N Valbuena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal CancerSudhir B Malla, David J Fisher, Enric Domingo, et al.
Cell Stem Cell|August 5, 2022
Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasiaEster Gil Vasquez, Nadia Nasreddin, Gabriel N Valbuena, et al.
Pageof 14